Related Concept Videos
Mitral Stenosis I: Introduction
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Myocarditis I: Introduction
Cytomegalovirus Disease
Mitral Valve Prolapse I: Introduction
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Initial Site of Macular Involvement in Central Retinal Dystrophies Revealed by Fundus Autofluorescence and Optical Coherence Tomography.
Genotype-Phenotype Correlations in RPGRIP1-Associated Retinal Dystrophy in a Nationwide Japanese Cohort.
Fundus Autofluorescence as a Sensitive Biomarker of Disease Progression in Bietti Crystalline Dystrophy.
Related Experiment Video
Updated: May 11, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
[Miyake's disease].
1Laboratory of Visual Physiology, National Institute of Sensory Organs.
Miyake's disease, or occult macular dystrophy (OMD), is a genetic condition causing vision loss with no visible eye abnormalities. Research identified dominant RP1L1 gene mutations as the cause of this progressive macular dystrophy.
Area of Science:
- Ophthalmology
- Genetics
- Retinal Diseases
Context:
- Miyake's disease (occult macular dystrophy, OMD) is a hereditary macular dystrophy.
- Characterized by progressive visual acuity decrease with normal fundus and fluorescein angiograms.
- Key diagnostic signs include normal full-field ERGs and abnormal focal macular ERGs.
Purpose:
- To detail the discovery and characteristics of Miyake's disease (OMD).
- To report the identification of the RP1L1 gene as causative for OMD.
- To consolidate understanding of OMD's genetic basis and clinical presentation.
Summary:
- Miyake's disease (OMD) involves hereditary macular degeneration with subtle fundus changes.
- Research identified dominant mutations in the RP1L1 gene as the cause of OMD.
- This gene is responsible for OMD in both Japanese and non-Japanese populations.
Impact:
- Established RP1L1 gene mutations as the primary cause of Miyake's disease.
- Provides a foundation for understanding the genetic mechanisms of macular dystrophies.
- Facilitates improved diagnosis and potential future therapeutic strategies for OMD.